Xeris Pharmaceuticals, Inc.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	2	1
2023	—	4	1
2022	—	3	1
2020	—	1	1
2019	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE CONAFAY GROUP, LLC	—	13

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	8
SENATE	7

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	10
Medicare/Medicaid	Medicare/Medicaid	4

Xeris Pharmaceuticals, Inc. — Lobbying Disclosure | Poliscope